Govt Wants To Reduce Compliance Burden On Pharma Sector: Mansukh Mandaviya

Mumbai : Union Minister for Chemicals and Fertilizers Mansukh Mandaviya on Thursday said that the government wants to reduce the compliance-burden on the pharma industry for ease of doing business.

Speaking as the chief guest at an Indian Drug Manufacturers’ Association (IDMA) event here, Mandivya, who is also the Minister for Health and Family Welfare, said that the Narendra Modi-led government at the Centre is not only pro-poor and pro-farmer but industry-friendly as well.

We want the ease of doing business for the industry and lessen the compliance burden on it. This is why we always carry out consultations with all stakeholders prior to the formulation of any policy or regulation (governing the pharma industry), Mandaviya said.

The government is helping the industry by amending the Drugs and Cosmetics Act, 1940 and promoting Ease of Doing Business, he said, adding, We are involving the industry in decision-making processes.

Also, through a series of webinars, the government has tried to reach out and consult industry and other stakeholders on the implementation of Union Budget provisions, the minister stated.

Our government is pro-poor, pro-farmer and industry-friendly government. It is dedicated to the poor and farmers but at the same time it is an industry-friendly government as well, he emphasized.

Stating that the industry plays an important role in nation-building and also in achieving self-reliance, the Minister said that today the Indian pharma industry is known in the world which is due to the efforts of both the Government and the industry.

He said that the government is working to make the pharma industry self-reliant and also enhancing and the introduction of the Rs 15,000 crore Productivity-Linked Incentive (PLI) scheme is a step in this direction.

Through the Production Linked Incentive Scheme, the government has tried to reduce imports by encouraging domestic manufacturing of pharmaceuticals, he said.

Manufacturing of 35 Active Pharma Ingredients (API), which used to be imported earlier, has started in the country now under the PLI Scheme for the pharma sector, Mandaviya said.

The Minister urged the pharmaceutical sector to prepare a plan for the next 25 years.

Government does not view the health sector as a profit-making industry. When we export medicines, we do it with an attitude of ‘Vasudhaiva Kutumbakam’. During the first wave of COVID-19 pandemic, India supplied medicines to 125 countries, he added.

  • Related Posts

    Offences Under Chapter IV Of Drugs And Cosmetics Act Triable Only By Sessions Court, Not Magistrate: Supreme Court

    New Delhi: The Supreme Court held that offences relating to manufacture and sale of drugs under Chapter IV of the Drugs and Cosmetics Act, 1940 cannot be tried by a…

    Drug Inspector, Aide Caught By ACB Taking ₹20,000 Bribe

    KAKINADA: Anti-Corruption Bureau (ACB) officials on Friday caught Drug Inspector Kampa Suresh Kumar of Jangareddygudem and his alleged private aide, Tadikamalla Siva Ramakrishna, red-handed while accepting a bribe of ₹20,000.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Offences Under Chapter IV Of Drugs And Cosmetics Act Triable Only By Sessions Court, Not Magistrate: Supreme Court

    Offences Under Chapter IV Of Drugs And Cosmetics Act Triable Only By Sessions Court, Not Magistrate: Supreme Court

    Drug Inspector, Aide Caught By ACB Taking ₹20,000 Bribe

    Drug Inspector, Aide Caught By ACB Taking ₹20,000 Bribe

    Ayush Ministry Busts Illegal Ayurvedic Drug Factory in Dehradun: Over Rs 1 Crore Cash, Fake Medicines Seized in Major Raid

    Ayush Ministry Busts Illegal Ayurvedic Drug Factory in Dehradun: Over Rs 1 Crore Cash, Fake Medicines Seized in Major Raid

    Maha govt seeks ₹26.5 crore for state-wide drug tracking system amid spurious medicine crackdown

    Maha govt seeks ₹26.5 crore for state-wide drug tracking system amid spurious medicine crackdown

    Punjab and Haryana HC refuses bail to pharma owner in Rs 600 crore drugs diversion case

    Punjab and Haryana HC refuses bail to pharma owner in Rs 600 crore drugs diversion case

    Galgotia Outrage in AI Expo evokes SOS from Domestic MedTech Industry

    Galgotia Outrage in AI Expo evokes SOS from Domestic MedTech Industry